BFRI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biofrontera Inc (BFRI).


$8.45M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

BFRI Market Cap. (MRY)


BFRI Shares Outstanding (MRY)


BFRI Assets (MRY)


Total Assets

$22.10M

Total Liabilities

$17.67M

Total Investments

$7.00K

BFRI Income (MRY)


Revenue

$37.32M

Net Income

-$17.76M

Operating Expense

$35.92M

BFRI Cash Flow (MRY)


CF Operations

-$10.27M

CF Investing

-$3.00K

CF Financing

$14.84M

BFRI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

BFRI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$22,101,000 (-20.88%)

$27,932,000 (-45.11%)

$50,884,000 (-4.39%)

$53,219,000 (120.48%)

Assets Current

$20,700,000 (-10.29%)

$23,075,000 (-46.51%)

$43,140,000 (-7.07%)

$46,421,000 (137.13%)

Assets Non-Current

$1,401,000 (-71.16%)

$4,857,000 (-37.28%)

$7,744,000 (13.92%)

$6,798,000 (49.01%)

Goodwill & Intangible Assets

$35,000 (-98.67%)

$2,629,000 (-13.29%)

$3,032,000 (-12.12%)

$3,450,000 (-10.83%)

Shareholders Equity

$4,433,000 (-7.51%)

$4,793,000 (-79.93%)

$23,878,000 (110.60%)

$11,338,000 (94.54%)

Property Plant & Equipment Net

$983,000 (-43.70%)

$1,746,000 (10.58%)

$1,579,000 (491.39%)

$267,000 (-27.84%)

Cash & Equivalents

$5,905,000 (339.69%)

$1,343,000 (-92.20%)

$17,208,000 (-29.89%)

$24,545,000 (203.77%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$7,000 (-91.03%)

$78,000 (-99.26%)

$10,548,000 (0%)

$0 (0%)

Investments Current

$7,000 (-91.03%)

$78,000 (-99.26%)

$10,548,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$6,646,000 (-39.07%)

$10,908,000 (52.18%)

$7,168,000 (60.79%)

$4,458,000 (-37.13%)

Trade & Non-Trade Receivables

$5,315,000 (2.96%)

$5,162,000 (-30.30%)

$7,406,000 (-40.42%)

$12,431,000 (277.96%)

Trade & Non-Trade Payables

$7,200,000 (-20.05%)

$9,006,000 (247.72%)

$2,590,000 (62.08%)

$1,598,000 (-6.77%)

Accumulated Retained Earnings (Deficit)

-$117,409,000 (-17.82%)

-$99,650,000 (-25.32%)

-$79,519,000 (-0.81%)

-$78,879,000 (-91.61%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$4,922,000 (-8.83%)

$5,399,000 (301.11%)

$1,346,000 (0%)

$0 (0%)

Debt Current

$548,000 (-88.07%)

$4,595,000 (822.69%)

$498,000 (0%)

$0 (0%)

Debt Non-Current

$4,374,000 (444.03%)

$804,000 (-5.19%)

$848,000 (0%)

$0 (0%)

Total Liabilities

$17,668,000 (-23.64%)

$23,139,000 (-14.32%)

$27,006,000 (-35.52%)

$41,881,000 (128.73%)

Liabilities Current

$12,021,000 (-33.54%)

$18,088,000 (-13.43%)

$20,894,000 (51.01%)

$13,836,000 (213.03%)

Liabilities Non-Current

$5,647,000 (11.80%)

$5,051,000 (-17.36%)

$6,112,000 (-78.21%)

$28,045,000 (101.91%)

BFRI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$37,321,000 (9.54%)

$34,071,000 (18.82%)

$28,674,000 (18.98%)

$24,100,000 (27.86%)

Cost of Revenue

$18,607,000 (6.67%)

$17,444,000 (14.88%)

$15,185,000 (19.17%)

$12,742,000 (40.55%)

Selling General & Administrative Expense

$33,835,000 (-13.53%)

$39,127,000 (11.36%)

$35,137,000 (-3.77%)

$36,512,000 (101.53%)

Research & Development Expense

$2,089,000 (2612.99%)

$77,000 (-89.50%)

$733,000 (5.16%)

$697,000 (0%)

Operating Expenses

$35,924,000 (-8.37%)

$39,204,000 (9.29%)

$35,870,000 (-5.51%)

$37,961,000 (97.21%)

Interest Expense

$2,035,000 (334.83%)

$468,000 (140.00%)

$195,000 (-43.31%)

$344,000 (-88.01%)

Income Tax Expense

$22,000 (57.14%)

$14,000 (-56.25%)

$32,000 (-42.86%)

$56,000 (-12.50%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$17,759,000 (11.78%)

-$20,131,000 (-3045.47%)

-$640,000 (98.30%)

-$37,713,000 (-243.25%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$17,759,000 (11.78%)

-$20,131,000 (-3045.47%)

-$640,000 (98.30%)

-$37,713,000 (-243.25%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$17,759,000 (11.78%)

-$20,131,000 (-3045.47%)

-$640,000 (98.30%)

-$37,713,000 (-243.25%)

Weighted Average Shares

$5,516,334 (256.74%)

$1,546,297 (46.29%)

$1,056,988 (140.00%)

$440,412 (38330.37%)

Weighted Average Shares Diluted

$5,516,334 (256.74%)

$1,546,297 (46.29%)

$1,056,988 (140.00%)

$440,412 (38330.37%)

Earning Before Interest & Taxes (EBIT)

-$15,702,000 (20.09%)

-$19,649,000 (-4657.63%)

-$413,000 (98.89%)

-$37,313,000 (-363.29%)

Gross Profit

$18,714,000 (12.55%)

$16,627,000 (23.26%)

$13,489,000 (18.76%)

$11,358,000 (16.10%)

Operating Income

-$17,210,000 (23.77%)

-$22,577,000 (-0.88%)

-$22,381,000 (15.87%)

-$26,603,000 (-181.04%)

BFRI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$3,000 (-100.48%)

$619,000 (112.01%)

-$5,156,000 (-46772.73%)

-$11,000 (0%)

Net Cash Flow from Financing

$14,835,000 (76.38%)

$8,411,000 (-40.01%)

$14,021,000 (-67.54%)

$43,191,000 (227.35%)

Net Cash Flow from Operations

-$10,270,000 (58.75%)

-$24,895,000 (-53.68%)

-$16,199,000 (39.36%)

-$26,715,000 (-115.98%)

Net Cash Flow / Change in Cash & Cash Equivalents

$4,562,000 (128.76%)

-$15,865,000 (-116.32%)

-$7,334,000 (-144.54%)

$16,465,000 (1895.76%)

Net Cash Flow - Business Acquisitions and Disposals

$57,000 (-90.87%)

$624,000 (112.19%)

-$5,118,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$10,000 (-100.00%)

-$5,000 (86.84%)

-$38,000 (-245.45%)

-$11,000 (0%)

Issuance (Repayment) of Debt Securities

-$265,000 (-106.79%)

$3,904,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$4,507,000 (-67.86%)

$14,021,000 (-67.54%)

$43,191,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,019,000 (-2.49%)

$1,045,000 (-43.57%)

$1,852,000 (1335.66%)

$129,000 (0%)

Depreciation Amortization & Accretion

$1,149,000 (7.99%)

$1,064,000 (-9.22%)

$1,172,000 (117.04%)

$540,000 (-3.91%)

BFRI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

50.10% (2.66%)

48.80% (3.83%)

47.00% (-0.21%)

47.10% (-9.25%)

Profit Margin

-47.60% (19.46%)

-59.10% (-2586.36%)

-2.20% (98.59%)

-156.50% (-168.44%)

EBITDA Margin

-39.00% (28.44%)

-54.50% (-2196.15%)

2.60% (101.70%)

-152.60% (-284.38%)

Return on Average Equity (ROAE)

-459.50% (-69.81%)

-270.60% (-8356.25%)

-3.20% (99.27%)

-439.40% (-587.14%)

Return on Average Assets (ROAA)

-81.90% (-43.43%)

-57.10% (-4658.33%)

-1.20% (98.77%)

-97.50% (-134.94%)

Return on Sales (ROS)

-42.10% (27.04%)

-57.70% (-4021.43%)

-1.40% (99.10%)

-154.80% (-262.53%)

Return on Invested Capital (ROIC)

-213.80% (30.13%)

-306.00% (-6020.00%)

-5.00% (98.72%)

-389.50% (-1144.41%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.34 (-59.15%)

-0.21 (99.29%)

-30.05 (-1611.39%)

-1.76

Price to Sales Ratio (P/S)

0.16 (27.78%)

0.13 (-81.36%)

0.68 (-75.40%)

2.75

Price to Book Ratio (P/B)

1.91 (117.22%)

0.88 (-14.44%)

1.02 (-89.74%)

9.99

Debt to Equity Ratio (D/E)

3.99 (-17.44%)

4.83 (326.88%)

1.13 (-69.38%)

3.69 (17.57%)

Earnings Per Share (EPS)

-3.22 (75.27%)

-13.02 (-2034.43%)

-0.61 (99.29%)

-85.63 (99.11%)

Sales Per Share (SPS)

6.77 (-69.29%)

22.03 (-18.78%)

27.13 (-50.42%)

54.72 (-99.67%)

Free Cash Flow Per Share (FCFPS)

-1.86 (88.42%)

-16.1 (-4.82%)

-15.36 (74.69%)

-60.68 (99.44%)

Book Value Per Share (BVPS)

0.8 (-74.06%)

3.1 (-86.28%)

22.59 (-12.25%)

25.74 (-99.49%)

Tangible Assets Book Value Per Share (TABVPS)

4 (-75.56%)

16.36 (-63.85%)

45.27 (-59.94%)

113.01 (-99.36%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

7 (333.33%)

-3

Enterprise Value Over EBITDA (EV/EBITDA)

-0.45 (-133.68%)

-0.19 (95.19%)

-4.01 (-32.35%)

-3.03

Asset Turnover

1.72 (77.97%)

0.97 (76.14%)

0.55 (-11.88%)

0.62 (-12.62%)

Current Ratio

1.72 (34.95%)

1.28 (-38.21%)

2.06 (-38.45%)

3.35 (-24.25%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$10,280,000 (58.71%)

-$24,900,000 (-53.35%)

-$16,237,000 (39.25%)

-$26,726,000 (-116.07%)

Enterprise Value (EV)

$6,567,640 (82.65%)

$3,595,830 (218.06%)

-$3,045,695 (-102.73%)

$111,505,195

Earnings Before Tax (EBT)

-$17,737,000 (11.83%)

-$20,117,000 (-3208.72%)

-$608,000 (98.39%)

-$37,657,000 (-244.75%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$14,553,000 (21.69%)

-$18,585,000 (-2548.62%)

$759,000 (102.06%)

-$36,773,000 (-390.83%)

Invested Capital

$9,062,000 (-19.60%)

$11,271,000 (1.58%)

$11,096,000 (-2.56%)

$11,388,000 (46.58%)

Working Capital

$8,679,000 (74.03%)

$4,987,000 (-77.58%)

$22,246,000 (-31.73%)

$32,585,000 (115.00%)

Tangible Asset Value

$22,066,000 (-12.79%)

$25,303,000 (-47.12%)

$47,852,000 (-3.85%)

$49,769,000 (145.54%)

Market Capitalization

$8,446,640 (100.93%)

$4,203,830 (-82.82%)

$24,472,305 (-78.39%)

$113,221,195

Average Equity

$3,864,500 (-48.05%)

$7,438,750 (-63.32%)

$20,280,500 (136.29%)

$8,583,000 (170.49%)

Average Assets

$21,691,500 (-38.42%)

$35,226,500 (-32.51%)

$52,192,750 (34.94%)

$38,678,500 (46.26%)

Invested Capital Average

$7,344,750 (14.36%)

$6,422,250 (-22.21%)

$8,256,000 (-13.81%)

$9,578,500 (-62.72%)

Shares

7,749,211 (410.61%)

1,517,628 (13.68%)

1,334,950 (77.33%)

752,800